Please use this identifier to cite or link to this item:
|Title:||Same admission laparoscopic cholecystectomy for acute cholecystitis: is the "golden 72 hours" rule still relevant?|
|Citation:||Tan J.K.H., Goh J.C.I., Lim J.W.L., Shridhar I.G., Madhavan K., Kow A.W.C. (2017-01-01). Same admission laparoscopic cholecystectomy for acute cholecystitis: is the "golden 72 hours" rule still relevant?. HPB 19 (1) : 47-51. ScholarBank@NUS Repository. https://doi.org/10.1016/j.hpb.2016.10.006|
|Abstract:||Background Studies have shown that same admission laparoscopic cholecystectomy (SALC) is superior to delayed laparoscopic cholecystectomy for acute cholecystitis (AC). While some proposed a“golden 72-hour” for SALC, the optimal timing remains controversial. The aim of the study was to compare the outcomes of SALC in AC patients with different time intervals from symptom onset. Methods A retrospective analysis of 311 patients who underwent SALC for AC from June 2010–June 2015 was performed. Patients were divided into three groups based on the time interval between symptom onset and surgery: <4 days (E-SALC), 4–7 days (M-SALC), >7 (L-SALC). Results The mean duration of symptoms was 2(1–3), 5(4–7) and 9 (8–13) days for E-SALC, M-SALC and L-SALC, respectively (p < 0.001). Conversion rates were higher in the L-SALC group [E-SALC, 8.2% vs M-SALC, 9.6% vs L-SALC, 21.4%] (p = 0.048). The total length of stay was longer in patients with longer symptom duration [E-SALC, 4 (2–33) vs M-SALC, 2 (2–23) vs L-SALC, 7 (2–49)] (p < 0.001). Conclusion Patients with AC presenting beyond 7 days of symptoms have higher conversion rates and longer length of stay associated with SALC. However, patients with less than a week of symptoms should be offered SALC. © 2016 International Hepato-Pancreato-Biliary Association Inc.|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Sep 17, 2018
checked on Sep 20, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.